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Membrane-cytoskeleton interfaceCa2+ signal transducers by regulating cellular targets in their Ca2+ bound
conformation. S100P is a member of the S100 protein family that can activate the membrane and F-actin
binding protein ezrin in a Ca2+ dependent manner at least in vitro. Here we generated a novel tool to
elucidate directly the S100P–ezrin interaction in vivo. This was achieved by constructing a S100P derivative
that contained mutations in the two EF hand loops predicted to lock the protein in a permanently active
state. The resulting S100P mutant, termed here S100P pa, could be puriﬁed as a soluble protein and showed
biochemical properties displayed by wild-type S100P only in the presence of Ca2+. Importantly, S100P pa
bound to the N-terminal domain of ezrin in the absence of Ca2+ showing an afﬁnity only slightly reduced as
compared to that of Ca2+-bound WT S100P. In line with this permanent complex formation, S100P pa
colocalized with ezrin to plasma membrane protrusions of epithelial cells even in the absence of intracellular
Ca2+ transients. Thus, S100P pa is a novel type of S100 protein mutant locked in a permanently active state
that shows an unregulated complex formation with its cellular target ezrin.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Cellular Ca2+ transients can be evoked by a wide range of
extracellular and intracellular stimuli. They serve important second
messenger functions by initiating signaling pathways that result in a
variety of responses ranging from altered gene expression to cell
shape changes, cell migration and apoptosis. Many proteins coupling
the initial Ca2+ signal to the downstream responses have been
described. Most of these proteins are directly regulated by ﬂuctuations
in cellular Ca2+ as they harbor Ca2+ binding sites of different afﬁnities.
One class of Ca2+ binding proteins is characterized by the EF hand, a
helix–loop–helix motif in which side chain and carbonyl oxygens
coordinate the Ca2+ ion. S100 proteins form the largest group of EF
hand proteins. They are short polypeptides of appr. 10 kDa and contain
two EF hands per molecule. Whereas the N-terminal EF hand deviates
slightly from the classical fold and has a rather low afﬁnity, the C-
terminal EF hand of S100 proteins is considered canonical and
typically has a Ca2+ afﬁnity in the micromolar range. S100 proteins
form homo- and heterodimers and in most cases these dimers
constitute the physiologically active unit (for reviews see [1–3]).
Ca2+ binding induces conformational changes in S100 proteins that
typically are characterized by a reorientation of helix E2 (the E helix of
the second EF hand) and result in the exposure of hydrophobic surfaces+49 251 8356748.
ll rights reserved.often involving residues found in the linker region between the two EF
hands and the C-terminal extension following the second EF hand (for
reviewsee [4,5]). The Ca2+bound conformation enables S100proteins to
bind to a large number of targets (effectors) occurring both intra- aswell
as extracellularly (for reviews see [2,3]).Within theS100 family, S100A10
represents an exception since it has suffered amino acid deletions and
substitutions in both EF hands that abolish Ca2+ binding and lock the
protein in a conformation resembling that of an active, Ca2+ bound S100
protein.Hence, S100A10 is able to forma tight, heterotetrameric complex
with its target, annexin A2, even in the absence of Ca2+ [6–8].
S100P is a member of the S100 family initially identiﬁed in
placenta [9]. It is expressed in a number of cells and tissues and is
signiﬁcantly upregulated in highly metastatic cancer cells suggesting
an involvement in tumor cell migration [10–12]. Upon Ca2+ binding,
S100P can interact with ezrin, a membrane-actin crosslinking protein.
Ezrin is a member of the ERM (ezrin–radixin–moesin) family of
proteins that are characterized by two principal domains, the N- and
C-terminal ERM association domains (ERMADs). In resting cells N-
and C-ERMAD interact with one another thereby masking the
membrane protein and lipid binding sites located in the N-ERMAD
and the F-actin binding site located in the C-ERMAD (for review see
[13]). S100P can bind to the N-ERMAD in masked or dormant ezrin
and this interaction activates ezrin's F-actin binding [14]. The S100P–
ezrin interaction is strictly Ca2+ dependent in vitro and also appears to
occur in vivo in stimulated cells upon intracellular Ca2+ elevation.
Moreover, experiments with Ca2+ ionophores suggest that
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leton crosslinking function of ezrin bypassing the need of protein
phosphorylation [14]. Together, these observations have fed the idea
that intracellular Ca2+ elevation results in Ca2+ binding to S100P and
that this Ca2+-bound S100P can in turn activate the ezrin molecule
inducing its translocation to the membrane cytoskeleton. However, it
is not known whether Ca2+ bound S100P is indeed an important
mediator in this order of events within cells.
To directly address this question we have constructed a S100P
mutant that should be locked in the active, Ca2+ bound conformation.
Structural predictions indicate that the three-dimensional fold of this
mutant, termed S100P pa for permanently active, resembles that of
Ca2+ loaded S100P. In vitro analyses reveal that S100P pa shows
biochemical properties that are displayed by wild-type S100P only in
the presence of Ca2+. Furthermore, S100P pa colocalizes with ezrin to
membrane protrusions and microvilli of resting cells whereas WT
S100P shows this property only after cell stimulation and intracellular
Ca2+ rise. This indicates that the S100P–ezrin interaction is strictly
dependent on the Ca2+ bound conformation of S100P also in vivo. The
S100P pa derivative described here constitutes the ﬁrst engineered
permanently active mutant among the S100 proteins and is expected
to serve as a useful tool in functional analyses of this and, by
extrapolation, other S100 proteins.
2. Materials and methods
2.1. Construction of plasmids
The cloning of pET28a+-, pEGFP-C2- and pGEX4T-1 constructs
encoding N-terminally histidine- or GFP-tagged human S100P WT, as
well as histidine- or GST-tagged ezrin's N-ERMAD (aa1–323) had been
described previously [14,15]. cDNA encoding the human S100P pa
mutant was generated by polymerase chain reactions using the
pET28a+ S100PWT plasmid as template andmutated oligonucleotide
primers containing the respective nucleotide-substitutions and
-deletions. For bacterial protein expression of His-tagged S100P WT,
S100P pa and N-ERMAD the respective cDNAs were cloned into
pET28a+ (Novagen) in frame with the 6× His-tag and, in case of GST-
tagged N-ERMAD, into the pGEX4T-1 vector (Amersham Bioscience)
in frame with the GST-tag. For the recombinant expression of non-
tagged proteins the cDNA of the S100P pa mutant was cloned into a
pET23a+ vector (Novagen, Madison, WI) modiﬁed to express the
recombinant proteinwithout T7 tag and, in the case of S100PWT, into
the pKK223-3 vector (Amersham Pharmacia Biotech Freiburg, Ger-
many). For localization analyses coding sequences of S100P deriva-
tives were cloned into the pEGFP-C2 vector (Clontech, Mountain View,
USA) to yield in frame fusion proteins with an N-terminal EGFP.
2.2. Cell culture
The human epidermoid carcinoma cell line A-431 was cultured in
RPMI 1640 medium (PAA, Linz, Austria) supplemented with 0.1 mM
non-essential amino acids, 1 mM sodium pyruvate, 2 mM L-glutamine,
10% heat-inactivated fetal bovine serum and antibiotics.
2.3. Transient transfection
A-431 cells were transiently transfected by nucleofection using
Nucleofector Kit T (Amaxa, Köln, Germany) and the recommended
program according to manufacturer's instructions. Following transfec-
tion A-431 cells were seeded on cover slips and cultured for 24 h.
2.4. Immunoﬂuorescence staining
To induce cell stimulation accompanied by an intracellular Ca2+
mobilization transiently transfected A-431 cells grown on cover slipswere transferred to growth media without FCS and cultured for 16 h.
10% heat-inactivated fetal bovine serum was then added and cells
were incubated for 30 min. Control non-stimulated cells were
maintained in FCS-free serum. Subsequently, cells were ﬁxed with
3% formaldehyde in PBS for 10 min at room temperature. After
quenching in 50 mM NH4Cl for 7 min cells were permeabilized with
0.2% Triton X-100 in PBS for 2min and incubated in PBS supplemented
with 2% BSA for 30 min. Cells were then incubated with an anti-ezrin
polyclonal antibody (Upstate, Lake Placid, USA) for 30min andwashed
three times with 2% BSA/PBS, followed by staining of the primary
antibody with Cy2-conjugated goat anti-rabbit secondary antibody
(Dianova, Hamburg, Germany). Cells were washed three times with
PBS, oncewith distilled H2O, mounted inMowiol and analyzed using a
confocal laser scanning microscope (LSM 510; Zeiss, Jena, Germany).
2.5. Recombinant expression and puriﬁcation of S100P WT, S100P pa and
N-ERMAD
pET28a+-constructs encoding N-terminally His-tagged WT and
mutant S100P, pET23a+ and pKK223-3 constructs encoding S100
derivatives without tag, as well as the pET28a+- and pGEX4T-1
constructs encoding ezrin's N-ERMAD with an N-terminal histidine-
or GST-tag were used to transform E. coli [strain BL21 (DE3)pLysS].
Transformed bacteria were grown to an OD600 of 0.6 and recombinant
protein expression was then induced by adding IPTG. After 3 h of
incubation, cells were harvested by centrifugation (5000 ×g, 10 min)
and resuspended in lysis buffer (40 mM Hepes, pH 7.2, 300 mM NaCl,
20 mM imidazole, pH 7.5, 1 mM EDTA, 10 mM β-mercaptoethanol,
1.5 mM PMSF). Subsequently, cells were lysed by repeated freeze/
thaw cycles (3 times) and sonication and the lysates were cleared by
centrifugation for 1 h at 100,000 ×g.
For preparation of His-tagged S100P WT the remaining super-
natant was adjusted to a Ca2+ concentration of 5 mM and applied to a
phenyl Sepharose (Pharmacia, Freiburg, Germany) column equili-
brated in lysis buffer containing 0.5 mM CaCl2 instead of EDTA. After
extensive washing with the same buffer, bound protein was eluted
with lysis buffer containing 1 mM EGTA. S100P-containing fractions
were pooled, dialysed against buffer N (20 mM imidazole, pH 7.5,
300 mM NaCl, 10 mM β-mercaptoethanol, 1.5 mM PMSF), and applied
to a Ni-NTA-agarose (Qiagen, Hilden, Germany) column equilibrated
in the same buffer. After several washing steps with buffer N, S100P
WT protein was eluted with 250 mM imidazole, pH 7.5, 300 mMNaCl,
10 mM β-mercaptoethanol and 1 mM PMSF.
For preparation of His-tagged S100P pa the cleared bacterial lysate
was directly applied to a Ni-NTA-agarose column and puriﬁed by
developing the column as described above for the His-tagged S100P
WT protein.
For preparation of non-tagged S100P WT the cleared bacterial
lysate was applied to a phenyl Sepharose column and puriﬁed by
developing the column as described above for the His-tagged S100P
proteins.
The non-tagged S100P pa protein was puriﬁed using anion
exchange chromatography. Therefore, the cleared bacterial lysate
was ﬁrst dialysed against buffer D (10 mM Hepes pH 7.2, 20 mM NaCl,
10 mM 2-mercaptoethanol, 1 mM PMSF) and then applied to a DEAE-
Sephacel (GE-Healthcare) column equilibrated in buffer D. After
extensive washing with buffer D, S100P pa protein was eluted with
10 mM Hepes pH 7.2, 500 mM NaCl, 10 mM 2-Mercaptoethanol and
1 mM PMSF.
The histidine-tagged N-ERMAD protein was puriﬁed as described
[14].
In the case of GST-tagged N-ERMAD the cleared bacterial lysate
was applied to a glutathione Sepharose 4B (Amersham Biosciences,
Uppsala, Sweden) column equilibrated in PBS containing 1.5 mM
PMSF. After extensive washing with the same buffer, bound N-ERMAD
proteinwas eluted with 100 mM glutathione, 50 mM Tris–HCl, pH 8.0.
Fig. 1. Predicted structural fold of the S100P pa mutant. (A) Sequence comparison of S100P and S100A10, the only S100 protein incapable of binding Ca2+ that is locked in a
permanently active state. Critical changes in the two EF hand loops that are presumably responsible for the active state of S100A10 are highlighted in red. The same changes were
incorporated in the S100P sequence to generate the S100P pa mutant. (B) (Left) Superimposition of apo (orange) and Ca2+ bound S100P (green) structures after MD simulations
emphasizing the change in the relative position of helix E2. A small helix (in red), linking helices F1 and E2, is present in Ca2+ bound S100P but unfolded in apo S100P. (Right)
Superimposition of Ca2+ bound S100P (green) and apo S100P pa (blue) structures after MD simulations. The structures are nearly identical and a small helix (in red) between helices
F1 and E2 is present in both structures. (C) Angle between helices F1 and E2 (averaged with an angle between helices F1′ and E2′ in the second protomer of the dimer) during 10 ns
MD simulation of S100P proteins. Ca2+ loaded S100P is shown in green, apo S100P in orange and mutant S100P pa in blue. This angle was initially the same in all three
structures. (D) Dimeric model of S100 pa highlighting hydrophobic residues in green. Left, ribbon representation of S100P pa model showing Tyr88 and Phe89 in stick type;
right, the solvent accessible surface of S100P pa reveals a deep and large hydrophobic cavity that is suited for target protein interaction.
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The ability of S100PWTand S100P pa to interact with hydrophobic
matrices was analyzed using phenyl Sepharose columns. 400 μg of the
puriﬁed His-tagged proteins was dialyzed against buffer D (40 mM
Hepes, pH 7.4, 300 mM NaCl, 20 mM imidazole, pH 7.4, 10 mM β-
mercaptoethanol, 1.5 mM PMSF) adjusted to a Ca2+ concentration of
5 mM, or to 1 mM EGTA (control) and centrifuged for 30 min at
100,000 ×g. Subsequently, the supernatants were applied to a phenyl
Sepharose column equilibrated in buffer D containing 0.5 mM CaCl2 or
1 mM EGTA. After extensive washing with the same buffer equal
amounts of the different fractions (non-bound, wash) and the
matrices were mixed with 4 x SDS sample buffer, then treated for
5 min at 95 °C and analyzed by 15% SDS-PAGE and subsequent
immunoblotting with anti-penta-His monoclonal mouse antibodies
(Qiagen, Hilden, Germany).
2.7. Column-based binding assays
The interaction between S100P derivatives and ezrin's N-ERMAD
was analyzed using afﬁnity columns containing one of the binding
partners in an immobilized form. To prepare afﬁnity columns GST-
tagged N-ERMAD was dialyzed against PBS containing 1.5 mM PMSF
and rebound to glutathione Sepharose 4B. The material was
transferred to 5 ml polypropylene columns (Pierce, Rockford, IL) and
washedwith PBS containing 0.5mMCaCl2 to remove unbound protein
and adjust the ﬂuid phase to an elevated Ca2+ concentration. His-
tagged S100P derivatives were then added in the ﬂuid phase, the
columns were washed extensively with PBS containing 0.5 mM CaCl2
to remove all non-speciﬁcally bound proteins and Ca2+-dependently
bound proteins were eluted with PBS containing 1 mM EGTA. Samples
of each elution and washing step as well as of the protein bound
matrices were then treated for 5 min at 95 °C with an equal volume of
4 x SDS sample buffer and analyzed by 15% SDS-PAGE and subsequent
immunoblotting with the respective antibodies.
2.8. Real time binding measured by surface plasmon resonance (SPR)
SPR experiments were performed with a Biacore 3000 system (GE
Healthcare).
2.8.1. N-ERMAD binding assay
Puriﬁed N-ERMAD was immobilized on a sensor surface, and S100P
derivativeswere passed over the chip in amobile aqueous phase. SensorFig. 2. Puriﬁed S100P pa interacts with hydrophobic matrices in a Ca2+ independent manner.
as described in Materials and methods. Puriﬁed proteinwas subjected to SDS-PAGE and stain
Puriﬁed S100P WT and S100P pa were applied to phenyl Sepharose in the presence (Ca2+) o
bound on the columnmatrix was released by SDS PAGE sample buffer. Identical aliquots of the
fraction (M) were analyzed by SDS PAGE and immunoblotting with an anti-penta-His antibChip CM5 was obtained from GE Healthcare. The HBS-P-EGTA ﬂow
buffer consisted of 10 mM HEPES (pH 7.4), 150 mM NaCl, 0.005% (v/v)
Tween 20 and 1 mM EGTA, was ﬁltered through 0.22 μm ﬁlters
(Millipore) and degassed before use. Immobilization on the sensor chips
employed amine coupling according to manufacturer's instructions.
Brieﬂy, using a ﬂow rate of 5 μl/min, the chip surfacewas activatedwith
an 8 min injection of a freshly prepared 1:1 mixture of 0.2 M N-ethyl-N
(3-diethylaminopropyl) carbodiimide (EDC) and 0.05 M N-hydroxy-
succinimide (NHS) solution, followed by injection of the protein,
typically at a concentration of 30 μg/ml in acetate buffer pH 5.0. When
the desired level of immobilization was achieved, unreacted N-
hydroxysuccinimide-ester groups were blocked with a 7 min injection
of 1 M ethanolamine hydrochloride. Sensograms (response units versus
time) were recorded at 25 °C with a typical ﬂow rate of 40 μl/min and
injection times of 3 min . Controls for the contribution of the change in
bulk refractive index were performed in parallel with blank ﬂow cells,
which were activated with EDC/NHS and deactivated with ethanola-
mine in the absence of protein to be coupled, and subtracted from all
binding sensograms. Blank injections of the running buffer were also
performed and subtracted from all the kinetic measurements.
To analyze the binding of S100P pa to immobilized N-ERMAD,
different concentrations of S100P pa diluted in ﬂow buffer at
concentrations ranging from 0.007 to 4.9 μM were injected into the
ﬂow cells. Each injection was repeated at least twofold for reprodu-
cibility. Regeneration of the surface was performed using two short
pulses of glycin/HCl buffer, pH 2.5.
Approximate equilibrium dissociation constants (KD) were obtained
by measuring the equilibrium resonance (Req) units at several ligand
concentrations at equilibrium. The afﬁnity of the interaction, i.e. the
equilibriumdissociation constant (KD),wasdetermined fromthe level of
binding at equilibrium as a function of the sample concentrations by
BIAevalution version 4.1 software (Biacore, Inc.). The steady state
binding level is related to the concentration according to the Scatchard
equation: Req/C=KARmax−ReqKA, where Rmax is the resonance signal
at saturation, C is the concentration of free analyte, and KA is the
equilibrium association constant.
2.8.2. F-actin binding assay
The actin binding assay was performed at 25 °C in 10 mM HEPES
(pH 7.5), 150 mM NaCl, 1 mM MgCl2, 1 mM EGTA and 0.005% Tween
20. Puriﬁed human nonmuscle actin (Cytoskeleton) was polymerized
according to the manufacturer's instruction. Brieﬂy, 9 μl of a 10 μg/μl
G-actin solution was incubated with 1 μl of 10 x polymerization
buffers (500 mM KCl, 20 mM MgCl2, 10 mM ATP) and incubated at(A) S100P pawas expressed recombinantly as non- and His-tagged version and puriﬁed
ed with Coomassie blue (lane 1, His-tagged S100P pa; lane 2, non-tagged S100P pa). (B)
r absence (EGTA) of Ca2+. The columns were washed extensively and protein remaining
non-bound fraction (F), the ﬁrst and last wash fraction (W1,W2) and thematrix bound
ody.
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diluted to 0.5 mg/ml in immobilization buffer (50 mM sodium acetate
pH 4.1, 12.5 mM KCl, 0.5 mM MgCl2 and 0.25 mM ATP) and
immobilized on the CM5 sensor chip (GE Healthcare) using the
amine coupling method as outlined above. About 4500 RU of F-actin
were immobilized on the sensor chip. A control ﬂow cell was
derivatized with the same method in the absence of F-actin.
Sensogramswere recorded at a ﬂow rate of 60 μl/min and injection
time of 2 min. Controls for the contribution of the change in bulk
refractive index were performed in parallel with blank ﬂow cells as
described above. Ezrin, Ezrin plus S100P pa (tagless) and ezrin plus
S100PWT(tagless) at concentrations of 35 μg/ml (4 timesmolar excess
of S100P)were injected into the ﬂow cells and long dissociation time of
90 min were used to allow the signal to stabilize to baseline levels.
2.9. Modeling the structure of the wild type and mutant S100P proteins
A complete structure of the wild type S100P protein was obtained
based on the crystal structure of the S100P protein with bound Ca2+
ions (PDB ID: 1J55) [16]. Therein folding of the protein fragment (Gln-
46 to Lys-51) not present in the crystal structure of S100P protein
(1J55) was predicted applying the MODELLER [17] program using the
structurally similar protein S100A10 (PDB ID: 1A4P) [7].
The structure of the S100P pa mutant protein was then predicted
based on the previously obtained structure of complete wild type
S100P. Three residues present in second EF hand responsible for Ca2+
coordination were mutated to corresponding amino acids seen in the
S100A10 structure (Asn-64 to Cys, Gln-68 to Lys, Glu-73 to Ser). Three
amino acids present in the ﬁrst EF hand loop (residues Ser-21, Glu-22,
Gly-23 in the S100P sequence) were removed since the equivalent
positions are missing in S100A10. The model of the full S100P pa
homodimer was subjected to energy minimizations using GROMACS
[18] and the stereochemistry of the ﬁnal model was analyzed with
PROCHECK [19].
2.10. Molecular dynamics simulations of S100P proteins
Threemolecular dynamics simulationswere conducted. Simulation
box (53 Å×75 Å×72 Å) consisted of a protein, 8956 water molecules
and ions. Systems under consideration involved Ca2+ boundwild type
S100P, wild type S100P in the absence of Ca2+ ions and S100P pa with
no Ca2+. Each system was optimized using 1000 steps of steepest
descent algorithm. The protocol for molecular dynamics simulation
was identical for three systems and involved three stages. First,1000 ps
molecular dynamics simulation was conducted with position
restraints imposed on all backbone atoms of the protein. In the second
stage, lasting 500 ps, position restraints were imposed only on C alpha
atoms of the protein. The last stage of the simulation involved 10 ns of
molecular dynamics simulation with no restraints. During the
calculations ffG43a1 forceﬁeld was used. System pressures were
isotropically coupled using the Berendsen barostat. The Particle
Mesh Ewald (PME) procedure [20] for treatment of long-range
electrostatics interactions was applied with the SPC water model.
Bond lengths were preserved with LINCS algorithm. Molecular
dynamics simulations were performed at 310 K with the simulation
step of 1 fs. All calculations and data analysis were accomplished using
VMD [21] and programs available from the GROMACS3.3 [18]
application. All proteins were simulated in dimeric forms.
3. Results and discussion
3.1. Construction and characterization of a permanently active S100P
mutant protein
To identify within human S100P residues whose mutation could
induce a fold similar to that of the Ca2+ bound, i.e. active, protein wecompared the sequences of S100P and S100A10. The latter was chosen
since it is the only Ca2+ insensitive S100 protein that is locked in a
permanentlyactive conformation resembling thatof a Ca2+boundS100
protein [7]. The comparison identiﬁes within S100A10 a deletion of
three amino acids in the ﬁrst EF hand loop (residues 21–23 in the S100P
sequence) and three substitutions of Ca2+ coordinating residues in the
second EF hand (Asn-64, Gln-68, Glu-73 in S100P) (Fig.1A). To evaluate
whether similar mutations in S100P would also result in a protein fold
resembling the Ca2+ bound conformationwe modeled the structure of
such mutant, herein referred to as S100P pa, which was constructed by
homology modeling to the published molecular structure of Ca2+
bound S100P [16] and subsequentmolecular dynamics simulation. This
template was also used for construction of wild type apo and Ca2+
bound S100Pproteins. Therefore, all changes in shapes of these proteins
resulted from the molecular motions calculated by the molecular
dynamics procedure. The superimposition of simulated apo S100P and
S100P pa reveals a substantial deviation, in particular in the position
of helix E2 (Fig. 1B, left). This shift of helix E2 resembles that seen upon
Ca2+ binding as shown in a superimposition of apo S100P and Ca2+
bound S100P [16]. A direct comparison of the knownCa2+bound S100P
and themodeled S100P pa structures indeed reveals the high degree of
similarity (Fig. 1B, right). Molecular dynamics simulations also show
that the angle between helices F1 and E2, a characteristic feature
distinguishing apo and Ca2+ bound S100 proteins is very similar for Ca2
+ S100P and S100P pa (Fig. 1C). As revealed by simulations the F1-E2
angle in S100P apo is very ﬂexible and ﬂuctuates between open (∼90°)
and close (∼45°) states. Furthermore, a small helix between helices F1
and E2 present in active S100 proteins (Ca2+ bound S100P and
S100A10) and facilitating binding of a ligand, is also present in S100P pa
but is unfolded in apo S100P. Thus, modeling and molecular dynamics
predict that the folding of S100P pa differs from apo S100P and more
closely resembles Ca2+ bound S100P. As expected from this close
similarity, S100Ppa is predicted to expose a large hydrophobic cavity on
its surface, a feature seenwith several other S100 proteins in their Ca2+
conformation (Fig. 1D). Interestingly, the exposed hydrophobic side
chains include Tyr-88 and Phe-89, previously shown to participate
in ezrin binding [15]. Furthermore, the modeling predicts that the
C-terminal helix of S100P pa elongates by 6 residues as observed in the
structure of Ca2+-bound S100P.
Based on these considerations and modelings we constructed the
S100P pa derivative by site-directed mutagenesis and expressed the
protein recombinantly in bacteria. S100P pa behaved as a soluble
protein and could be puriﬁed from the bacterial lysates indicative of a
proper folding (Fig. 2A). We next analyzed its ability to interact with
hydrophobic matrices: a biochemical hallmark of Ca2+ bound S100
proteins. Whereas WT S100P bound to phenyl Sepharose only in the
presence of Ca2+ and could be stripped off upon Ca2+ chelation with
EGTA, S100P pa was able to interact with the hydrophobic matrix also
in the absence of Ca2+. Moreover, bound S100P pa could not be
removed by EGTA treatment (Fig. 2B). In line with the structure
predictions (Fig. 1) these results indicate that S100P pa adopts the
conformation of a Ca2+ bound S100 protein exposing hydrophobic
side chains on the surface of the molecule.
3.2. S100P pa interacts with ezrin in the absence of Ca2+
Given the Ca2+ independent exposure of possible target protein
binding sites in S100P pa we next analyzed whether S100P's
intracellular target, the membrane-cytoskeleton linker protein ezrin,
also binds S100P pa and whether this binding is rendered Ca2+
insensitive. Therefore the N-ERMAD of ezrin, previously shown to
harbor the S100P binding site [14], was immobilized on Sepharose
beads and probed with S100P or S100P pa added in the ﬂuid phase. In
this assay, WT S100P interacts with immobilized N-ERMAD in the
presence of Ca2+ and can be eluted by Ca2+ chelation with EGTA
(Fig. 3A). No appreciable binding is seenwhen the interaction analysis
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to immobilized N-ERMAD both, in the presence and absence of Ca2+.
Furthermore, the bound S100P pa cannot be released when the
column was washed with EGTA (Fig. 3A).
To obtain a quantitative value for the stability of the N-ERMAD-
S100P pa complex, the interaction was also analyzed by surface
plasmon resonance (SPR) using the Biacore system. SPR analyses had
shown a Ca2+ dependent interaction of S100P WT with N-ERMAD,
which was determined by titration experiments to have an apparent
KD of appr. 0.3 μM [15]. SPR experiments also reveal a clear interaction
of S100P pa with N-ERMAD immobilized on the sensor chip with
binding occurring in the presence (not shown) but also the absence of
Ca2+ (Fig. 3B). Evaluation of the titration studies depicted in Fig. 3B by
a solid state afﬁnity (Scatchard) approach yielded a KD of appr. 1.45 μM
for the interaction betweenN-ERMADand Ca2+ free S100P pa (Fig 3C).
Through binding to the N-ERMAD, S100P WT is known to activate the
capacity of ezrin to interact with F-actin. This activity is strictly Ca2+
dependent, thus requiring the active Ca2+ conformation of S100P [14].
To elucidate whether S100P pa is also capable of activating ezrin's F-
actin binding capacity and whether such activation can occur in the
absence of Ca2+ we performed F-actin binding studies. In these
analyseswe also relied on SPRusing F-actin immobilized on the sensor
chip as this method was described recently for an analysis of the
binding of huntington-interacting protein-1 related (HIP1R) to F-actin
[22]. Fig. 3D reveals that S100P pa can increase the binding of full-
length ezrin to the immobilized F-actin in the absence of Ca2+. This
increase is not seenwith Ca2+-free S100PWTandmost likely reﬂects a
S100P pa-mediated activation of ezrin's F-actin binding capacity. It has,
however, to be noted that these studies show a substantial degree of
ezrin-F-actin interaction already in the absence of S100P. This must
reﬂect a partial activation of the recombinantly expressed ezrin
possibly occurring by proteolysis during protein puriﬁcation.
Together, the biochemical characteristics of S100P pa are consis-
tent with the structure modeling. Interactions involving hydrophobic
protein surfaces, i.e. binding to phenyl Sepharose and the intracellular
target ezrin, are observed in the absence of Ca2+ albeit with a slightly
reduced afﬁnity. While S100P WT binding to N-ERMAD occurs with a
KD of appr. 0.3 μM, the afﬁnity of the S100P pa mutant is reduced appr.
5fold (KD of appr. 1.45 μM) indicative of a still suboptimal folding of
the binding pocket. Although we have not examined the contributionFig. 3. Ca2+ independent interaction of S100P pa with N-ERMAD. (A) Afﬁnity
chromatography analysis. Puriﬁed GST-tagged N-ERMAD was bound to glutathione
Sepharose columns and puriﬁedWT S100P and S100P pawere added in the ﬂuid phase.
Binding reactionswere carried out in the presence of either Ca2+ or EGTA (seeMaterials
and methods) and ﬂow through fractions were collected (F). After extensive washing
with Ca2+ or EGTA-containing buffers (W), respectively, the columns were developed
with an EGTA-containing buffer to elute Ca2+ dependently bound proteins (E). Material
remaining on the matrix was released by boiling in SDS PAGE sample buffer. Equivalent
amounts of all fractions were subjected to SDS-PAGE and analyzed by western blotting.
S100P proteins were detected using an anti-penta-His antibody and N-ERMAD using an
anti-GST antibody. Note the Ca2+ independent binding of S100P pa to N-ERMAD. In
contrast, WT S100P requires Ca2+ for a signiﬁcant binding to GST-N-ERMAD. (B)
Interaction of S100P pa with immobilized N-ERMAD analyzed by surface plasmon
resonance (SPR). Appr. 700 response units (RU) of N-ERMAD were immobilized on the
CM5 sensor chip using the amine coupling method as described in Materials and
methods. S100P pa at concentrations between 0.007 and 4.9 μM was injected and
allowed to react with the sensor chip surface at a ﬂow rate of 40 μl/min and an injection
time of 3 min. Each injection was repeated twice for reproducibility. The average
binding level at the end of injection (equilibrium) was used for calculation of the steady
state afﬁnity. (C) Steady state afﬁnity determined from the level of binding at
equilibrium (Req) as a function of the sample concentration. Calculationwas carried out
using the BIAevaluation software version 4.1, as described in Materials and methods. An
approximate dissociation constant of 1.45 e−6 M was calculated for the binding of
S100P pa to N-ERMAD. (D) S100P pa increases F-actin binding of ezrin in the absence of
Ca2+. Appr. 4000 response units of F-actin were immobilized on the CM5 sensor chip
using amine coupling as described in Materials and methods. Ezrin, ezrin plus non-
tagged S100P pa or ezrin plus non-tagged S100PWT (35 μg/ml) were injected at a ﬂow
rate of 60 μl/min and injection time of 2 min. Binding reactions were carried out in the
presence of 1 mM EGTA to exclude Ca2+-dependent effects. All sensograms are
corrected using a blank control ﬂow cell as reference. RU, response units.
Fig. 4. Intracellular distribution of S100P WT and S100P pa. A-431 cells transiently expressing GFP-S100P WT or GFP-S100P pa were kept in serum-free medium and either left
unstimulated or stimulated with FCS for 30 min. Cells were then ﬁxed with formaldehyde, permeabilized and stained with rabbit anti-ezrin polyclonal antibody followed by
appropriate ﬂuorescently-labeled secondary antibodies. Note the serum-induced appearance of plasma membrane protrusions and microvilli that are seen in cells expressing S100P
WT. These structures are positive for ezrin and, in many cases, also S100P. Similar membrane structures are observed in the GFP-S100P pa expressing cells even in the absence of
serum stimulation. Cell stimulation does not change this pattern. In each case the lower panels show a higher magniﬁcation of the area indicated, highlighting the co-localization of
ezrin and GFP-S100P WT and GFP-S100P pa to microvillar membrane protrusions. Some nuclear localization of S100P WT, S100P pa and ezrin is seen to variable extents under all
conditions. The reason for this nuclear signal is not known, it might be due to the ectopic overexpression saturating cytosolic or plasmamembrane binding sites. Bar represents 10 μm.
1084 J. Austermann et al. / Biochimica et Biophysica Acta 1793 (2009) 1078–1085
1085J. Austermann et al. / Biochimica et Biophysica Acta 1793 (2009) 1078–1085of the individual mutations to the overall conformation of S100P pa,
the three amino acid deletion in the ﬁrst EF hand loop is likely to have
a major impact. This deletion causes a shift of helix F1 that in turn
places the E2 helix in a position corresponding to that occupied in the
Ca2+ bound form. As a result the angle between helices F1 and E2 is
similar in S100P pa and Ca2+ bound WT S100P thereby exposing the
C-terminal aromatic side chains on the protein surface.
3.3. S100P pa colocalizes with ezrin to surface protrusions in non-
stimulated cells
To analyze whether a Ca2+ independent association of S100P pa
with ezrin is also seen invivoweperformed colocalization studies in A-
431 human epithelial cells. These cells show abundant ezrin-positive
surface protrusions andmicrovilli once stimulatedwith growth factors
or serum. Cell stimulation is accompanied by an intracellular Ca2+ rise
that in turn signals through downstreammediators to the cortical actin
cytoskeleton. Our previous work had identiﬁed S100P as one down-
stream mediator, most likely involved in a Ca2+ dependent activation
of ezrin that results in the translocation of ezrin to the plasma
membrane and the induction of microvilli [14]. Although this
translocation and the formation of microvilli is also seen when
intracellular Ca2+ is elevated by ionophore treatment, it is not
known whether the Ca2+ effect is the consequence of an activation
of S100P by Ca2+ binding and a resulting interaction of Ca2+ bound
S100Pwith ezrin. Given the characteristics of the S100P pamutant this
could now be tested directly by analyzing the potential colocalization
of S100P pa and ezrin in A-431 cells. Due to the lack of S100P pa-
speciﬁc antibodies we performed these experiments with A-431 cells
ectopically expressing GFP fusion proteins of WT S100P and S100P pa.
Such N-terminal GFP fusions had been shown previously not to
interfere with target protein binding [14]. Cells were analyzed for the
distribution of the S100P derivatives and endogenous ezrin either after
serum starvation to induce a resting phenotype, or following serum
treatment for 30 min. Fig. 4 (upper panels) reveals that serum
stimulation triggers the induction of membrane protrusions and
microvilli that are positive for ezrin and S100P. No signiﬁcant co-
localization of the two proteins is seen in resting cells, i.e. at low
intracellular Ca2+ levels. In contrast, GFP-tagged S100P pa already
colocalizes with ezrin to microvillar membrane protrusions in the
absence of serum stimulation indicative of an unregulated interaction.
In this case serum stimulation did not change the intracellular
distribution of the two proteins (Fig. 4, lower panels). Cells expressing
GFP-S100P pa not only show a permanent plasma membrane
localization of ezrin, they also have an increased number of membrane
protrusions indicative of a dominant activating effect of S100P pa.
Through the use of the permanently active S100P mutant these
analyses provide evidence for the direct activation of ezrin by S100P
within cells. Since in wild-type cells activation can be triggered by Ca2
+ elevation and since S100P pa appears to induce the same type of
activation, Ca2+ signaling in this scenario seems to involve Ca2+
binding to S100P and the direct interaction of Ca2+ bound S100P with
ezrin. In addition to helping to resolve this question of Ca2+ mediated
ezrin activation, the properties of the S100P pa mutant show that it is
possible to generate permanently and probably dominantly active
S100 protein derivatives to be tested in future functional studies
within cells and organisms. This should allow for the ﬁrst time a directanalysis of the effect of Ca2+ bound S100 proteins on their targets in a
cellular context circumventing complex signaling cascades.
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